A new study could be the key to treating triple negative cancer, one of the most complex types of cancer that is difficult to treat. During the experiments, researchers from UConn Well being and the Jackson Laboratory for Genomic Medication (JAX) managed to stop the spread of this cancer throughout the body.

According to the Herald Publicist, scientists have found that blocking a protein editing DNA can prevent triple aggressive breast cancer from spreading throughout the body, that is, metastasizing.

The creation of a real drug that can affect defects in the editing of breast cancer genes is still a long way off, but there is already a drug on the market that corrects the same defects that cause a certain form of muscle atrophy in children. Researchers claim that their findings suggest that this expensive medicine can also be used to treat aggressive breast cancer and other diseases.

Triple negative cancer is the most aggressive type of breast cancer with a very high probability of metastases, relapses and death within five years after diagnosis.